Summary.-The levels of T, B and null lymphocytes in the peripheral blood, draining lymph nodes, and tumour masses at different growth stages in dogs transplanted with canine transmissible venereal sarcoma (CTVS) were determined by immunofluorescence techniques. The tumours were classified at excision into "progressor", "steady state", and "regressor" stages of growth. The percentage of B cells in the lymphocytes infiltrating into the progressively growing tumours (n = 10, 37-3 +7.4°) was significantly higher (P < 0025) than that in regressing tumours (n =21, 26.1 + 1.9%). In contrast, the percentage of T cells in the lymphocytes infiltrating into the regressing tumours (n=21, 61-2 +2.6%) was significantly higher (P <0.005) than that in the progressively growing tumours (n = 10, 34-0 + 5.1%). The tumours at the steadystate growth stage (n =9) had 50-8 + 5.70 infiltrating T-cells, which was significantly higher (P < 0.005) than the progressors and lower (P < 0-005) than the regressors. The percentage of null cells of progressors (n=10, 260+6-9%) was significantly (P< 0.025) higher than in regressors (n=21, 13-5+2-9%). The draining lymph nodes of progressor dogs (n=5) had significantly fewer (P <0-025) B cells (8-2 +2.3 %) than in normal (n=5, 16
1.9%). In contrast, the percentage of T cells in the lymphocytes infiltrating into the regressing tumours (n=21, 61-2 +2.6%) was significantly higher (P <0.005) than that in the progressively growing tumours (n = 10, 34-0 + 5.1%). The tumours at the steadystate growth stage (n =9) had 50-8 + 5.70 infiltrating T-cells, which was significantly higher (P < 0.005) than the progressors and lower (P < 0-005) than the regressors. The percentage of null cells of progressors (n=10, 260+6-9%) was significantly (P< 0.025) higher than in regressors (n=21, 13-5+2-9%). The draining lymph nodes of progressor dogs (n=5) had significantly fewer (P <0-025) B cells (8-2 +2.3 %) than in normal (n=5, 16.1 +3.1%), regressors (n= 12, 19.1 + 1.7%) and steady-state dogs (n =5, 15-8 + 2.6%). Although there was slight lymphopenia and fluctuation of null cells, no significant differences in T-and B-lymphocyte levels were noted in the peripheral blood of the tumour dogs (n=44) studied.
EVALUATION OF THE IMMUNE RESPONSE elicited from neoplasms is of great importance in developing an effective immunotherapy for cancer patients through an understanding of the host-tumour relationship. It involves the study of changes in cell populations and functions of both peripheral lymphoid cells (Silverman et al., 1976; Lee et al., 1977; Domagala et al., 1978; Garnes & Lala, 1978; Klein et al., 1976; Klobusicka et al., 1978; Wood & Neff, 1978; Svennevig et al., 1979; Santer et al., 1980) and those infiltrating into tumours (Edelson et al., 1975; Holden et al., 1976; Vose et al., 1977a, b; Blazar & Heppner, 1978; Domagala et al., 1978; Svennevig et al., 1978; Konorza et al., 1979; Thynne et al., 1979) . These reports, however, reflected the complex nature of the host-tumour relationship and indicated the need for a time-course study to determine types, number, and function of infiltrating lymphocytes and macrophages (LM cells) from the time of tumour take through rapid growth and spontaneous regression.
It occurred to us that the canine transmissible venereal sarcoma (CTVS) would be ideal for such a study. The tumour can be transplanted into non-preconditioned dogs, in which metastases can occur in neonatally inoculated puppies, whereas regression can occur in adults after a period of rapid growth (Yang & Jones, 1973; Cohen, 1973 Cohen, , 1980 . Furthermore, it has previously been observed that the percentage of viable LM cells out of total viable cells in tumour-cell suspensions was inversely correlated with the log of the tumour mass. This suggests that the degree of LM-cell infiltration is a measure of the host's immune response (Yang & Jones, 1973) . However, an estimate of the surface area of the tumour, well perfused with blood elements, showed that the LM mass in a tumour was a function of its surface area. Thus the inverse correlation of the percentage of viable LM cells in a viable tumour-cell suspension with the log of the tumour mass might not necessarily indicate that infiltrated LM cells were active as immune effector cells (Yang et al., 1976) . For further assessment of this phenomenon the infiltrating LM cells need to be characterized.
In this communication we report B, T, and null-cell levels in the peripheral blood, draining lymph nodes, and tumour masses at progressive, steady-state, and regressive stages of growth. Function studies will be presented in a subsequent paper.
MATERIALS AND METHODS
Dogs-Forty-four dogs, 28 beagles (17 M, 11 F), 13 collie dogs (4 M, 9 F), and 3 female, Labrador-collie crossbred dogs, ranging in age from 3 months to 2 years, were used in this study. An additional 13 beagles (8 M, 5 F) were used as normal controls. All dogs were housed, fed, and received water ad libitum at the Spring Hill Research Farm of the University of Connecticut.
Tumour transplantation.-A naturally occurring CTVS was the source of the tumour cells used for the laboratory transplantations. At passage, single tumour-cell suspensions were made by mincing the freshly collected tumours in Hanks' balanced salt solution (HBSS) containing penicillin and streptomycin. Dogs were inoculated s.c. in the interscapular region with 5-10 x 107 trypan-blueexcluding tumour cells (Yang & Jones, 1973 Isolation of lymphocytes.-Peripheral-blood lymphocytes (PBL): Venous blood (10 ml) was collected from tumour-bearing dogs into heparinized tubes (preservative-free sodium heparin, Fellows Medical Manufacturing Co., Oak Park, Mich.) before killing and exsanguination. A 0-5ml aliquot of blood was used for making smears and white and red cell counts with the use of a Coulter Counter (Model fn, Coulter Electronics, Inc., Hialeah, Fla). The remainder of the blood was centrifuged at 210 g for 10 min at room temperature. The buffy coat was removed, suspended to 6 ml with HBSS, and layered over a linear sucrose polymer-diatrizoate density gradient, as described by Muscoplat et al. (1977) . The resulting band of lymphocytes was removed and washed in HBSS. Cytocentrifuge (Cytospin, Model SCA-0031, Shandon Southern Products, Ltd, Runcorn, Cheshire) smears were made of the cell suspension for differential cell counts. After blood had been collected, the dog was killed with T-61 (National Laboratories Corp., Somerville, N.J.) and exsanguinated by cardiac puncture to minimize the tissue contamination by peripheralblood cells.
Lymph-node lymphocytes: The draining (prescapular) lymph nodes were removed, minced with scissors in HBSS, and the freed cells were washed. Cytocentrifuge smears were made of the cell suspension.
Lymphocytes from the tumour mass: The tumour mass was weighed and minced with scissors in HBSS. After washing, the cells were suspended to 6 ml with a cell concentration of 2-3 x 107 viable cells/ml (50-80% were trypan-blue-excluding cells). The suspension was layered over a linear sucrose polymer-diatrizoate density gradient, as described for peripheral-blood lymphocytes. Statistical analysis.-The data obtained were evaluated by a one-way analysis of variance or t test, depending on the appropriateness of the evaluation.
RESULTS

Classification of tumour
Forty-four dogs and their CTVS tumours were classified at the time of killing into one of the 3 categories described in Materials and Methods. Twenty-three dogs had regressing tumours which ranged in weight from 1P8 to 29-4 g; these dogs consisted of 9 M and 5 F beagles, 3 M and 5 F collies, and 1 F Labrador-collie crossbred. Eleven dogs had progressing tumours, which ranged in weight from 113-0 to 3086 g; these dogs consisted of 3 M and 5 F beagles, 2 F collies and 1 F Labrador-collie crossbred. Ten dogs had steady-state tumours which ranged in weight from 50-4 to 95-9 g; these dogs consisted of 5 M and 1 F beagles, 1 M and 2 F collies, and 1 F Labrador-collie crossbred.
Peripheral-blood leucocyte counts Table I shows the mean percentage and absolute counts of the peripheral blood leucocytes of the 13 normal (control) beagles and the 3 groups of tumour-bearing dogs. Basophils were rarely seen and hence were not included in this analysis. There were no statistically significant differences between the beagles, collie dogs, and Labrador-collie crossbreds within each group of tumour-bearing dogs, so their data were grouped together. Analysis of variance revealed that all groups of tumour-bearing dogs had significantly reduced percentages (P < 0.05) and absolute (P < 0.05) counts of lymphocytes when compared to the normal dogs. The mean percentages were 33 6 + 0.4 % for the normal dogs and 28-7 + 2.2%, 22-5 + 2.8%, and 28*2 + 2.0% for the regressor, progressor, and steady-state tumour dogs respectively. The mean absolute counts of lymphocytes for the normal dogs were 4 52 + 020x 103/1l and 3 36 + 0 26 ,u, 3-24 + 0-46 ,ul, and 3-49 + 0 33 x lO3/pl for the regressor, progressor, and steady-state dogs respectively. In contrast, there were no significant differences between the normal and tumour dogs for the total leucocyte, and for percentages and absolute counts of neutrophils, monocytes, and 7-6 + 0-9 3 07 + 0-38 9 0+ 1-9 3-17+0 77 11-3 + 1-7 4-34 + 0-72 9-6+3-1 2-66+0-87 eosinophils. Although the progressor and steady-state dogs had higher percentages and absolute monocyte counts than the normal dogs, the variation within each group was quite large and differences were not statistically significant.
Peripheral-blood lymphocyte subpopulations
The specificity of the immunofluorescence reagents was determined by the method described by Holden et al. (1976) and Wood & Neff (1978) . Lymphocytes, incubated at 37°C overnight in Ig-free medium, washed x 6, incubated with heatinactivated IgG for 1 h at 40C, and incubated at 4°C for 45 min with FITCconjugated rabbit anti-dog IgM serum, did not appreciably alter the percentage of SIg+ cells reported below, indicating that the method used does not detect monocytes with cytophilically acquired SIgs. The rabbit anti-dog thymocyte serum has been shown in a previous study (Chandler & Yang, 1981) to be T-cellspecific and, through the use of FITCconjugated goat anti-rabbit Ig (Alexander & Sanders, 1977) , it was felt that the Tlymphocyte population was properly defined.
As shown in Table II , no significant differences in the percentages and absolute counts of B, T, and null lymphocytes were demonstrable, though the absolute counts of B cells for the progressor and steadystate dogs (4.75 + 0'96 and 4-43 + 1-07 x 102/pl respectively) were lower than for normal dogs (7.15 + 0-67 x 102/ikl). The T-and B-cell absolute counts in general were lower for the tumour-bearing dogs, owing to the overall reduction of lymphocytes in these dogs (Table I) .
Draining lymph-node lymphocyte subpopulation
The percentages of SIg+, T-cell-antigenpositive, and null cells of 5 normal (2 M and 1 F collies and 1 M and 1 F beagle) and the 3 groups of tumour dogs are shown in Table III Steadystate (7) 91-2+1-4 1-3+0 5 3-3+0-6 06 +0 3 0 3-6+1-6 * Significantly different (P < 0.005) from the other two. (Korn et al., 1978; Svennevig et al., 1979) . Null 13 5+2 9 }p<0-025 2 + 69 f 23-9 + 8-6 Further analyses of the subpopulations of the infiltrating lymphocytes showed that the regressing tumours had higher percentages of T cells than progressive tumours, and that B cells, and possibly null cells, were more prevalent in progressive tumours. The functional role of individual lymphocyte subpopulations and their combinations in progressive tumour growth and spontaneous regression need to be established by functional studies of these lymphocytes. However, it would appear that T cells are the ones which contribute most significantly to the rejection of the tumour. It has been demonstrated that T cells are responsible for allograft rejection (Emerson, 1978) and regression of the Moloney sarcoma (Russell et al., 1976) .
In contrast, the prevalence of B cells in progressive tumours may underscore their role in tumour growth. For example, Wood & Neff (1978) suggested that there was an altered B-cell pattern in the presence of malignant neoplasms. This altered flow of B cells may also have been present in the dogs which had just received the tumour transplant and those which did not undergo rejection. Indeed, we have observed that the draining lymph nodes of dogs with progressively growing tumours had significantly lower percentages of B cells. Whether this tumour in its early stages of growth is chemo-attractive to B cells remains to be determined.
The significance of the null-cell population infiltrating the tumour is not known. Their identification was based on the absence of markers under study, and their number was lowest of all the cell types. However, it is of interest to note that the null-cell population fluctuated, and did not appear to parallel that of the B and T cells in the peripheral blood. All the CTVS-bearing dogs experienced a moderate lymphopenia, in which total T and B cells remained at a relatively constant level. The null-cell fluctuation may thus represent a reserve role in replenishing certain lymphocyte subpopulations.
Although absolute numbers of lymphocyte populations have not been determined, the ratios of the lymphocyte populations in the tumour and draining lymph nodes do reflect the presence of different immune responses induced by tumours at different states of growth. These findings may suggest that B cells are preferentially attracted to progressively growing tumours and/or are stimulatory to tumours. Since there were more T cells in regressors and B cells in progressors, the presence of more null cells in the progressors suggests also that the differentiation pathway of null cells may hold the key to the fate of the tumour. However, changes in the populations of lymphocytes in the peripheral lymphoid tissues do not necessarily define the response of dogs to this tumour.
Although the present findings of changes in lymphocyte subpopulations may or may not be tumour-specific, our functional studies (e.g. leucocyte adherence inhibition (LAI) test (Harding & Yang, 1981) ) with tumour-associated antigen (Palker & Yang, 1981) and normal tissue alloantigens, suggest that most of the changes are tumour-specific. Evaluation of the functional capacity of lymphocytes from dogs with progressive and regressive tumours is described in a subsequent paper.
